Primary liver cancers
Understanding hepatocellular carcinoma and cholangiocarcinoma better, to develop new therapeutic strategies.
Home · Research
Research
Better care through research
Intense translational research, working directly in the service of care, led by the HepaReg laboratory.
▶ Research at the Centre in video
The laboratory
HepaReg, the liver-disease laboratory
Research is part of care. At the heart of the Centre, the HepaReg laboratory — "Physiopathogenesis and treatment of liver diseases" — carries out translational research: questions raised at the bedside shape the projects, and the results come back to care.
A joint research unit (Inserm UMR-S 1193) under Inserm and Université Paris-Saclay, HepaReg brings together five teams of researchers and clinicians, from liver transplantation to new therapies against fulminant hepatitis and primary liver cancers.
Inserm UMR-S 1193Inserm · Université Paris-Saclay5 research teams
Translational research on liver diseasesResearch themes
Understanding and treating liver diseases
From liver cancers to hepatitis and transplantation, HepaReg pursues translational research, from the laboratory to the bedside.
Viral and fulminant hepatitis
From the physiopathology of hepatitis — viral and fulminant — to innovative treatments and the management of liver failure.
Transplantation & liver repair
Preserving and rehabilitating grafts with perfusion machines that keep the liver in near-physiological conditions — and sometimes repair it before transplantation.
Stem cells & organoids
Growing liver cells and organoids to model disease and explore new cell therapies.
Clinical research & trials
A clinical research unit coordinates the trials and studies run at the Centre, to bring advances to patients quickly.